ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in ImageneBio, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- −12 vs. Q2 2024
- Shares held
- 28.4M
- −246.0K (−0.9%) vs. Q2 2024
- Total value
- $49.1M
- +$1.86M (+3.9%) vs. Q2 2024
- New holders
- 6
- 12 more added
- Sold out
- 18
- 19 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $8.68M | 0.80% | 00.0% | Unchanged |
| BVF Inc | 4,769,164 | $8.25M | 0.24% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 4,091,118 | $7.08M | 1.37% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,539,358 | $6.12M | 0.11% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 2,249,123 | $3.89M | 2.43% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,384,664 | $2.40M | 0.00% | +20,194+1.5% | Added |
| Adage Capital Partners GP, L.L.C. | 987,900 | $1.71M | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 723,288 | $1.25M | 0.74% | +138,174+23.6% | Added |
| NEA Management Company, LLC | 600,063 | $1.04M | 0.06% | +30,013+5.3% | Added |
| Acuitas Investments, LLC | 449,656 | $777.9K | 0.35% | +49,777+12.4% | Added |
| Renaissance Technologies LLC | 400,600 | $693.0K | 0.00% | −75,800−15.9% | Reduced |
| Jacobs Levy Equity Management, Inc | 388,748 | $672.5K | 0.00% | −35,629−8.4% | Reduced |
| Sofinnova Investments, Inc. | 382,616 | $661.9K | 0.05% | 00.0% | Unchanged |
| BlackRock, Inc. | 352,176 | $609.3K | 0.00% | +352,176 | New |
| Acadian Asset Management LLC | 325,713 | $562.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 271,026 | $469.0K | 0.00% | +14,319+5.6% | Added |
| Millennium Management LLC | 249,417 | $431.5K | 0.00% | −105,293−29.7% | Reduced |
| FNY Investment Advisers, LLC | 231,383 | $400.0K | 0.19% | +231,383 | New |
| Two Sigma Advisers, LP | 202,100 | $349.6K | 0.00% | +28,900+16.7% | Added |
| Barclays PLC | 195,311 | $337.9K | 0.00% | −733−0.4% | Reduced |
| Citadel Advisors LLC | 165,015 | $285.5K | 0.00% | −79,675−32.6% | Reduced |
| Bridgeway Capital Management, LLC | 158,400 | $274.0K | 0.01% | +76,100+92.5% | Added |
| Two Sigma Investments, LP | 156,713 | $271.1K | 0.00% | −80,165−33.8% | Reduced |
| BBR Partners, LLC | 130,000 | $224.9K | 0.02% | +110,000+550.0% | Added |
| Vazirani Asset Management LLC | 115,668 | $200.1K | 0.36% | +115,668 | New |
| Deuterium Capital Management, LLC | 80,579 | $139.4K | 0.26% | +10.0% | Added |
| State Street Corp | 80,353 | $139.0K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 72,890 | $126.1K | 0.02% | 00.0% | Unchanged |
| JBF Capital, Inc. | 72,647 | $125.7K | 0.02% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 58,623 | $101.4K | 0.00% | −215,211−78.6% | Reduced |
| Susquehanna International Group, LLP | 57,090 | $98.8K | 0.00% | −26,128−31.4% | Reduced |
| Prelude Capital Management, LLC | 50,638 | $87.6K | 0.01% | +50,638 | New |
| Northern Trust Corp | 48,109 | $83.2K | 0.00% | −168,742−77.8% | Reduced |
| ADAR1 Capital Management, LLC | 44,635 | $77.2K | 0.01% | −2,050−4.4% | Reduced |
| Dimensional Fund Advisors LP | 38,621 | $66.8K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 38,374 | $66.4K | 0.00% | +18,607+94.1% | Added |
| Jane Street Group, LLC | 37,270 | $64.5K | 0.00% | −18,570−33.3% | Reduced |
| Prudential Financial Inc | 29,800 | $51.6K | 0.00% | 00.0% | Unchanged |
| Corsair Capital Management, L.P. | 24,830 | $43.0K | 0.01% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 22,146 | $38.3K | 0.01% | −23,374−51.3% | Reduced |
| Berkshire Asset Management LLC | 20,000 | $33.0K | 0.00% | 00.0% | Unchanged |
| JustInvest LLC | 17,795 | $30.8K | 0.00% | −515−2.8% | Reduced |
| Qube Research & Technologies Ltd | 17,352 | $30.0K | 0.00% | −17,589−50.3% | Reduced |
| Morgan Stanley | 15,403 | $26.6K | 0.00% | −25,471−62.3% | Reduced |
| Charles Schwab Investment Management Inc | 12,066 | $20.9K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 12,000 | $20.8K | 0.00% | +12,000 | New |
| Point72 (DIFC) Ltd | 6,716 | $11.6K | 0.00% | +2,324+52.9% | Added |
| Catalyst Funds Management Pty Ltd | 4,500 | $7.79K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 2,728 | $4.72K | 0.00% | +412+17.8% | Added |
| Tower Research Capital LLC (TRC) | 1,875 | $3.24K | 0.00% | −18,257−90.7% | Reduced |
| Advisor Group Holdings, Inc. | 1,503 | $2.60K | 0.00% | +1,503 | New |
| JPMorgan Chase & Co | 849 | $1.47K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 299 | $518 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 199 | $344 | 0.00% | −128−39.1% | Reduced |
| Farther Finance Advisors, LLC | 108 | $187 | 0.00% | −62−36.5% | Reduced |
| Nisa Investment Advisors, LLC | 99 | $171 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 72 | $125 | 0.00% | −41,746−99.8% | Reduced |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −135,297−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −73,431−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −64,641−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −60,628−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −44,933−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −30,240−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −28,053−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −27,666−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −26,893−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −21,861−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,607−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −16,270−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −5,005−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −4,842−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −3,856−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,585−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −985−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −283−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |